Biological Aggressiveness of Subclinical No-Mass Ductal Carcinoma In Situ (DCIS) Can Be Reflected by the Expression Profiles of Epithelial-Mesenchymal Transition Triggers

B. Szynglarewicz, Piotr Kasprzak, Piotr Donizy, Przemysław Biecek, Agnieszka Hałoń, Rafał MatkowskiInternational Journal of Molecular Sciences 2018 · DOI

TL;DR

This study investigates how the expression of specific protein markers related to epithelial-mesenchymal transition (EMT) in early-stage breast cancer (DCIS) can predict the likelihood of it progressing to invasive cancer. The researchers found that the combined expression of Snail1 and SPARC proteins in biopsy samples is a strong indicator of this progression, allowing for better risk stratification and potentially more personalized treatment decisions.

What Problem Does This Paper Address?

Ductal Carcinoma In Situ (DCIS) is a non-invasive form of breast cancer, but a significant portion of these lesions can progress to invasive cancer. Currently, managing DCIS involves a degree of uncertainty, as it's challenging to distinguish between indolent cases that may not require aggressive treatment and those with a high risk of invasion. This leads to a dilemma of either overtreating many patients or potentially under-treating a subset with aggressive disease. The paper aims to address this by identifying reliable biomarkers from early-stage biopsies that can predict the risk of postoperative invasion, thereby improving clinical decision-making.

Methods

The study utilized immunohistochemistry to assess the expression levels of three key epithelial-mesenchymal transition (EMT) biomarkers: N-cadherin, Snail1, and SPARC (secreted protein acidic and rich in cysteine). These markers were analyzed in biopsy specimens from 209 patients diagnosed with pure DCIS. The researchers then correlated the preoperative expression patterns of these biomarkers with the presence of invasive cancer found in subsequent surgical specimens (postoperative upgrading). Statistical analyses, including univariate and multivariate analyses, were employed to determine the predictive value of individual biomarkers and their combined expression profiles for invasion risk.

Datasets

The study used a dataset of 209 consecutive patients diagnosed with pure DCIS via percutaneous stereotactic vacuum-assisted breast biopsy. These patients underwent subsequent surgical resection, and the pathological findings from both the biopsy and surgical specimens formed the basis of the analysis. No new datasets were introduced.

Key Insights and Ideas

  • EMT as a predictor of invasion: The study reinforces the role of EMT in cancer progression, specifically showing its relevance in the early stages of breast cancer.
  • Combined biomarkers are better: While individual biomarkers showed some predictive power, their combined analysis, particularly Snail1 and SPARC, provided a much more nuanced and accurate risk stratification.
  • Indolent vs. Aggressive DCIS subtypes: The research successfully identified distinct subtypes of DCIS based on biomarker expression, ranging from those with a very low risk of invasion to those with a high likelihood of progression.
  • N-cadherin's limited role in early DCIS: Interestingly, N-cadherin expression, a known EMT marker, did not show a statistically significant association with postoperative invasion in this study, suggesting its role might be more prominent in later stages or that its predictive power is overshadowed by other markers in early DCIS.

Key Results

  • Prevalence of biomarkers: N-cadherin was found in 8% of tumors, Snail1 in 62%, and SPARC in 38%.
  • Individual biomarker significance: Both Snail1 and SPARC were significant independent predictors of postoperative invasion. SPARC showed a slightly stronger impact (higher Odds Ratio).
  • Combined biomarker power:
    • DCIS with single positive expression of either SPARC or Snail1 had a lower risk of invasion compared to double-positive cases.
  • DCIS with a double-positive profile (both SPARC and Snail1 positive) had a significantly higher risk of invasion.
  • Crucially, double-negative DCIS (SPARC-/Snail1–) showed no cases with invasive foci postoperatively, suggesting these might be truly indolent.
  • Conversely, DCIS with combined high SPARC and Snail1 expression (intermediate or strong) had an invasive component in 66-100% of tumors, indicating a highly aggressive subtype.

Limitations and Future Work

  • N-cadherin's limited role: The study acknowledges that the lack of a significant association for N-cadherin might be due to the small number of positive cases, potentially limiting statistical power.
  • Observational study: The study is observational, and no comparison with other EMT biomarkers was performed.
  • Intra- and inter-observer variability: Immunohistochemical staining assessment can be subject to variability.
  • Single-institution study: The findings are based on a single institution's data, which might limit generalizability.
  • Future Work: The authors suggest that these findings can help tailor treatment strategies, potentially leading to more selective surgery and the avoidance of unnecessary procedures in low-risk patients. Further research could explore other EMT markers and their combined predictive value. The identification of indolent and aggressive DCIS subtypes opens avenues for more personalized management.

Summary updated

Abstract

Epithelial-mesenchymal transitions (EMTs) have been recently implicated in the process of cancer progression. The aim of this study was to assess how the preoperative expression patterns of EMT biomarkers correlate with the risk of postoperative invasion in ductal carcinoma in situ (DCIS) found on stereotactic breast biopsies. N-cadherin, Snail1, and secreted protein acidic and rich in cysteine (SPARC) immunoreactivity was observed in 8%, 62%, and 38% of tumors, respectively. Snail1 and SPARC expressions were significantly related to N-cadherin expression and to each other. The postoperative upgrading rate was associated with a positive preoperative expression of all biomarkers. Significance of Snail1 and SPARC persisted in multivariate analysis, but the impact of SPARC on invasion was more significant. When these two EMT triggers were considered together, the risk of invasion did not significantly differ between the subtypes of DCIS with single positive expression (SPARC-/Snail1+ vs. SPARC+/Snail1-). However, it was significantly lower in single-positive DCIS when compared to lesions of a double-positive profile (SPARC+/Snail1+). Moreover, there were no cases in the double-negative DCIS (SPARC-/Snail1-), with foci of infiltrating cancer found postoperatively in residual postbiopsy lesions. In contrast, DCIS with a combined high SPARC and Snail1 expression (intermediate or strong) had an invasive component in 66⁻100% of tumors.
BibTeX
@article{szynglarewicz2018biological,
  author = {B. Szynglarewicz and Piotr Kasprzak and Piotr Donizy and Przemysław Biecek and Agnieszka Hałoń and Rafał Matkowski},
  title = {{Biological Aggressiveness of Subclinical No-Mass Ductal Carcinoma In Situ (DCIS) Can Be Reflected by the Expression Profiles of Epithelial-Mesenchymal Transition Triggers}},
  journal = {International Journal of Molecular Sciences},
  year = {2018},
  doi = {10.3390/ijms19123941},
}
Figure